Solara Active Pharma Sciences share price
You have to be logged in to add this to Watchlist.- ₹539.45(4.06%)April 24, 2025 13:18:58 PM IST
- NSE
- BSE
- Vol : 94.28K (NSE + BSE)Last 20 day avg : 91.46 K
Solara Active Pharma Sciences is trading 4.06% upper at Rs 539.45 as compared to its last closing price. Solara Active Pharma Sciences has been trading in the price range of 548.00 & 521.75. Solara Active Pharma Sciences has given -23.62% in this year & 0.11% in the last 5 days. There are 1 analysts who have initiated coverage on Solara Active Pharma Sciences. There are 0.00 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 8.09 Crores in its last quarter.Listed peers of Solara Active Pharma Sciences include Panacea Biotec (4.99%), Morepen Laboratories (14.64%), Solara Active Pharma Sciences (4.06%).The Mutual Fund holding in Solara Active Pharma Sciences was at 1.28% in 31 Mar 2025. The MF holding has decreased from the last quarter. The FII holding in Solara Active Pharma Sciences was at 14.63% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 24, 2025, 07:53 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BIn line with historical values2.17The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- BetaHigh volatility1.57Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry1.08The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 20.74% from Rs 300.31 crore to Rs 248.73 crore, year-on-year
- Company has registered a profit of 8.09 cr vs a loss of 275.34 cr in the same quarter last year.
The debt to equity of the company is higher than the industry median- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 560.50
- R2
- 608.30
- R3
- 656.85
- S1
- 464.15
- S2
- 415.60
- S3
- 367.80
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Panacea Biotec | Bullish | 538.85 | 4.99 | 3,300.50 | - | 3.67 | - | 2.49 |
| Morepen Laboratories | Neutral | 62.40 | 14.64 | 3,412.05 | 28.66 | 3.25 | - | 0.40 |
| Solara Active Pharma Sciences | Neutral | 539.45 | 4.06 | 2,606.43 | - | 2.18 | - | 12.58 |
| Suven Life Sciences | Bullish | 140.70 | 7.49 | 3,065.87 | - | 10.27 | - | - |
| Alembic | Neutral | 106.82 | -0.32 | 2,742.95 | 10.08 | 1.24 | 2.28 | 0.34 |
- Pledged found - Promoter(s) have pledged 34.64% of shares.
- Promoter(s) have decreased pledged shares to 40.74% from 34.64% earlier.
- Promoter(s) holding is moderate at 37.94%
- Promoter(s) have increased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has decreased by 0.04 percentage points from previous quarter
- Mutual Funds holding is constant over the last quarter at 1.28%
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-04-02 | Others |
| 2025-03-26 | Rights Issue & Others |
| 2025-01-24 | Quarterly Results |
| 2024-10-21 | Quarterly Results |
| 2024-07-22 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE624Z01016
- BSE Code541540
- NSE CodeSOLARA
Solara Active Pharma Sciences is trading at 539.45 as on Thu Apr 24 2025 07:48:58. This is 4.06% upper as compared to its previous closing price of 518.40.
The market capitalization of Solara Active Pharma Sciences is 2606.43 Cr as on Thu Apr 24 2025 07:48:58.
The average broker rating on Solara Active Pharma Sciences is . The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 1 analysts have given a strong sell rating
The 52 wk high for Solara Active Pharma Sciences is 885.95 whereas the 52 wk low is 366.95
Solara Active Pharma Sciences can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 31.53
- Dividend Yield: 0.00%
- D/E ratio: -
Solara Active Pharma Sciences reported a net profit of -567.39 Cr in 2024.
The Mutual Fund Shareholding was 1.28% at the end of 31 Mar 2025.